Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Income from Non-Controlling Interests (2018 - 2021)

Amphastar Pharmaceuticals has reported Income from Non-Controlling Interests over the past 4 years, most recently at -$2.4 million for Q4 2021.

  • Quarterly results put Income from Non-Controlling Interests at -$2.4 million for Q4 2021, down 592.72% from a year ago — trailing twelve months through Dec 2021 was -$731000.0 (down 124.24% YoY), and the annual figure for FY2021 was -$1.2 million, down 287.25%.
  • Income from Non-Controlling Interests for Q4 2021 was -$2.4 million at Amphastar Pharmaceuticals, down from $1.4 million in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for AMPH hit a ceiling of $6.6 million in Q4 2019 and a floor of -$2.4 million in Q4 2021.
  • Median Income from Non-Controlling Interests over the past 4 years was $870500.0 (2019), compared with a mean of $1.0 million.
  • Biggest five-year swings in Income from Non-Controlling Interests: surged 292.27% in 2019 and later tumbled 592.72% in 2021.
  • Amphastar Pharmaceuticals' Income from Non-Controlling Interests stood at $1.7 million in 2018, then surged by 292.27% to $6.6 million in 2019, then crashed by 92.77% to $481000.0 in 2020, then tumbled by 592.72% to -$2.4 million in 2021.
  • The last three reported values for Income from Non-Controlling Interests were -$2.4 million (Q4 2021), $1.4 million (Q3 2021), and -$855000.0 (Q2 2021) per Business Quant data.